ID

22400

Description

Adjuvant Chemotherapy in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT00677118

Lien

https://clinicaltrials.gov/show/NCT00677118

Mots-clés

  1. 01/06/2017 01/06/2017 -
Téléchargé le

1 juin 2017

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Nasopharyngeal Carcinoma NCT00677118

Eligibility Nasopharyngeal Carcinoma NCT00677118

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. patients with newly histologically confirmed non-keratinizing carcinoma (according to world health organization (who) histologically type)
Description

histologically confirmed non-keratinizing carcinoma

Type de données

boolean

Alias
UMLS CUI [1,1]
C1334926
UMLS CUI [1,2]
C0679557
2. tumor staged as n2-3or t3-4n1 (according to 6th american joint committee on cancer staging system)
Description

Tumor stage

Type de données

boolean

Alias
UMLS CUI [1,1]
C1300072
UMLS CUI [1,2]
C1334926
3. no evidence of distant metastasis (m0)
Description

distant metastasis

Type de données

boolean

Alias
UMLS CUI [1,1]
C1302548
UMLS CUI [1,2]
C1334926
4. performance status: kps ≥70
Description

karnofsky

Type de données

boolean

Alias
UMLS CUI [1]
C0206065
5. with normal liver function test (alanine aminotransferase、aspartate aminotransferase ≤2.5×upper limit of normal)
Description

ALT, AST

Type de données

boolean

Alias
UMLS CUI [1]
C0201836
UMLS CUI [2]
C0201899
6. renal: creatinine clearance ≥60ml/min
Description

creatinine clearance

Type de données

boolean

Alias
UMLS CUI [1]
C0373595
7. adequate marrow: leucocyte count ≥4000/μl, hemoglobin ≥80g/l and platelet count ≥100000/μl
Description

leucocyte count, hb, platelet count

Type de données

boolean

Alias
UMLS CUI [1]
C0023508
UMLS CUI [2]
C0518015
UMLS CUI [3]
C0032181
8. written informed consent
Description

informed consent

Type de données

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. who type keratinizing squamous cell carcinoma or basaloid squamous cell carcinoma.
Description

keratinizing squamous cell carcinoma, basaloid squamous cell carcinoma

Type de données

boolean

Alias
UMLS CUI [1]
C0334247
UMLS CUI [2]
C1266005
2. age ≥70 or <18
Description

age

Type de données

boolean

Alias
UMLS CUI [1]
C0001779
3. with a history of renal disease
Description

history of renal disease

Type de données

boolean

Alias
UMLS CUI [1,1]
C0262926
UMLS CUI [1,2]
C0022658
4. prior malignancy
Description

prior malignancy

Type de données

boolean

Alias
UMLS CUI [1]
C2735088
5. previous chemotherapy or radiotherapy
Description

previous chemotherapy or radiotherapy

Type de données

boolean

Alias
UMLS CUI [1]
C1514457
UMLS CUI [2]
C0279134
6. patient is pregnant or lactating
Description

pregnancy, breast feeding

Type de données

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
7. unstable cardiac disease requiring treatment.
Description

unstable cardiac disease requiring treatment

Type de données

boolean

Alias
UMLS CUI [1,1]
C0443343
UMLS CUI [1,2]
C0018799
UMLS CUI [1,3]
C0815189
8. emotion disturbance
Description

emotion disturbance

Type de données

boolean

Alias
UMLS CUI [1]
C0233459

Similar models

Eligibility Nasopharyngeal Carcinoma NCT00677118

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
histologically confirmed non-keratinizing carcinoma
Item
1. patients with newly histologically confirmed non-keratinizing carcinoma (according to world health organization (who) histologically type)
boolean
C1334926 (UMLS CUI [1,1])
C0679557 (UMLS CUI [1,2])
Tumor stage
Item
2. tumor staged as n2-3or t3-4n1 (according to 6th american joint committee on cancer staging system)
boolean
C1300072 (UMLS CUI [1,1])
C1334926 (UMLS CUI [1,2])
distant metastasis
Item
3. no evidence of distant metastasis (m0)
boolean
C1302548 (UMLS CUI [1,1])
C1334926 (UMLS CUI [1,2])
karnofsky
Item
4. performance status: kps ≥70
boolean
C0206065 (UMLS CUI [1])
ALT, AST
Item
5. with normal liver function test (alanine aminotransferase、aspartate aminotransferase ≤2.5×upper limit of normal)
boolean
C0201836 (UMLS CUI [1])
C0201899 (UMLS CUI [2])
creatinine clearance
Item
6. renal: creatinine clearance ≥60ml/min
boolean
C0373595 (UMLS CUI [1])
leucocyte count, hb, platelet count
Item
7. adequate marrow: leucocyte count ≥4000/μl, hemoglobin ≥80g/l and platelet count ≥100000/μl
boolean
C0023508 (UMLS CUI [1])
C0518015 (UMLS CUI [2])
C0032181 (UMLS CUI [3])
informed consent
Item
8. written informed consent
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
keratinizing squamous cell carcinoma, basaloid squamous cell carcinoma
Item
1. who type keratinizing squamous cell carcinoma or basaloid squamous cell carcinoma.
boolean
C0334247 (UMLS CUI [1])
C1266005 (UMLS CUI [2])
age
Item
2. age ≥70 or <18
boolean
C0001779 (UMLS CUI [1])
history of renal disease
Item
3. with a history of renal disease
boolean
C0262926 (UMLS CUI [1,1])
C0022658 (UMLS CUI [1,2])
prior malignancy
Item
4. prior malignancy
boolean
C2735088 (UMLS CUI [1])
previous chemotherapy or radiotherapy
Item
5. previous chemotherapy or radiotherapy
boolean
C1514457 (UMLS CUI [1])
C0279134 (UMLS CUI [2])
pregnancy, breast feeding
Item
6. patient is pregnant or lactating
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
unstable cardiac disease requiring treatment
Item
7. unstable cardiac disease requiring treatment.
boolean
C0443343 (UMLS CUI [1,1])
C0018799 (UMLS CUI [1,2])
C0815189 (UMLS CUI [1,3])
emotion disturbance
Item
8. emotion disturbance
boolean
C0233459 (UMLS CUI [1])

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial